StockTipsArenaBeta

BUY Anthem Biosciences Limited — Sumeet Bagadia, Choice Broking

BUYAnthem Biosciences Limited
Anthem Biosciences share price target & all analyst calls

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Intraday)4 Nov 2026, 9:03 am ISTvia Zee Business (Live)

Entry₹862.4Inferred
Target₹865
Total upside +0.30% (call closed)
Stop loss₹840-2.60% risk
Exit₹8654 Nov 2026, 9:15 am
Target hit+0.30%0.00%upside left
Follow Sumeet Bagadia for new calls(14% target hit, 83 closed calls)Get alertsWatch ANTHEM for new buy/sell callsGet alertsSee 1 active Intraday pick this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 4 Nov 2026
2 supporting1 neutral0 opposing
Supports the BUY call (2)

Anthem Biosciences reported Q2 FY27 consolidated revenue of ₹5,940 million, EBITDA of ₹3,304 million, and PAT of ₹2,115 million, showing year-on-year growth in profitability and margins.

BSE · Company Update·3 Nov · today

(opens in new tab)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·3 Nov · today

Neutral / worth noting (1)

The company reported its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.

BSE · Board Meeting·3 Nov · today

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Anthem Biosciences

All analyst calls on Anthem Biosciences

More from Sumeet Bagadia, Choice Broking

Every call and its outcome